Publication:
Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies

Thumbnail Image

Files

Interim2017_18InfluenzaSeasonal_2018.pdf (533.4 KB)
Identifiers
URI: http://hdl.handle.net/20.500.12105/8992
ISSN: 1560-7917
DOI: 10.2807/1560-7917.ES.2018.23.9.18-00086

Publication date

2018

Authors

Advisors

Journal Title

Journal ISSN

Volume Title

Publishers

Metrics
Google Scholar
Export
MarcXML METS

Research Projects

Organizational Units

Journal Issue

Abstract

Between September 2017 and February 2018, influenza A(H1N1)pdm09, A(H3N2) and B viruses (mainly B/Yamagata, not included in 2017/18 trivalent vaccines) co-circulated in Europe. Interim results from five European studies indicate that, in all age groups, 2017/18 influenza vaccine effectiveness was 25 to 52% against any influenza, 55 to 68% against influenza A(H1N1)pdm09, -42 to 7% against influenza A(H3N2) and 36 to 54% against influenza B. 2017/18 influenza vaccine should be promoted where influenza still circulates.

Description

Keywords

Europe Case control study Influenza Influenza vaccination Influenza vaccine effectiveness Multicentre study

MeSH Terms

Adolescent Adult Aged Child Child, Preschool Europe European Union Female Humans Infant Infant, Newborn Influenza A Virus, H1N1 Subtype Influenza A Virus, H3N2 Subtype Influenza B virus Influenza Vaccines Influenza, Human Male Middle Aged Pandemics Treatment Outcome Vaccination Seasons

DeCS Terms

Bibliographic citation

Euro Surveill. 2018 Mar;23(9):18-00086.

Collections

Centro Nacional de Epidemiología (CNE)
Centro Nacional de Microbiología (CNM)
IdiSNA - Instituto de Investigación Sanitaria de Navarra (Navarra)

Publisher version

https://doi.org/10.2807/1560-7917.ES.2018.23.9.18-00086

Related dataset

Related publication

Document type

research article